Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,100 | -920 | N/A | -1,310 | -3,520 |
| Depreciation Amortization | 10 | 10 | N/A | 20 | 10 |
| Other Working Capital | 600 | 500 | N/A | 810 | 360 |
| Other Operating Activity | 730 | 710 | 0 | 780 | 3,090 |
| Operating Cash Flow | $240 | $300 | $N/A | $300 | $-60 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -410 | -460 | 0 | -190 | 0 |
| Investing Cash Flow | $-410 | $-460 | $N/A | $-190 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 20 | 10 |
| Financing Cash Flow | $0 | $0 | $N/A | $20 | $10 |
| Beginning Cash Position | 200 | 200 | N/A | 60 | 60 |
| End Cash Position | 30 | 40 | N/A | 200 | 10 |
| Net Cash Flow | $-170 | $-150 | $N/A | $140 | $-50 |
| Free Cash Flow | |||||
| Operating Cash Flow | 240 | 300 | N/A | 300 | -60 |
| Free Cash Flow | 240 | 300 | 0 | 300 | -60 |